Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2011-11-25

Product name:

DIFFERIN

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02376660

Product Monograph/Veterinary Labelling:

Date: 2021-09-28 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

GALDERMA CANADA INC
SUITE 400 55 Commerce Valley Drive West
Thornhill
Ontario
Canada L3T 7V9

Class:

Human

Dosage form(s):

Lotion

Route(s) of administration:

Topical

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

84:92.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

D10AD03 ADAPALENE

Active ingredient group (AIG) number:See footnote5

0127242001

List of active ingredient(s)
Active ingredient(s) Strength
ADAPALENE 0.1 %
Version 4.0.2
Date modified: